Seeing Is Believing
Currently out of the existing stock ratings of Marie Thibault, 108 are a BUY (92.31%), 9 are a HOLD (7.69%).
Analyst Marie Thibault, currently employed at BTIG, carries an average stock price target met ratio of 54.95% that have a potential upside of 34.38% achieved within 112 days.
Marie Thibault’s has documented 236 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ICAD, icad inc at 17-Apr-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/21/2021. The price target of $21 was fulfilled within 1 day with a profit of $2.58 (14.01%) receiving and performance score of 140.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$137
$8.15 (6.33%)
$125
12 days ago
(17-Apr-2025)
12/13 (92.31%)
$6.02 (4.60%)
390
Buy
$145
$16.15 (12.53%)
$133
12 days ago
(17-Apr-2025)
2/3 (66.67%)
$14.02 (10.70%)
133
Buy
$159
$30.15 (23.40%)
$158
12 days ago
(17-Apr-2025)
19/24 (79.17%)
$28.02 (21.39%)
465
Buy
$145
$16.15 (12.53%)
$135
12 days ago
(17-Apr-2025)
14/15 (93.33%)
$14.02 (10.70%)
298
Buy
$160
$31.15 (24.18%)
$127
1 months 25 days ago
(04-Mar-2025)
14/16 (87.5%)
$19.78 (14.11%)
487
Which stock is Marie Thibault is most bullish on?
Which stock is Marie Thibault is most reserved on?
What Year was the first public recommendation made by Marie Thibault?